ShockWave Medical (SWAV) Financial Analysis & Valuation | Quarter Chart
ShockWave Medical (SWAV)
SWAVPrice: $334.75
Fair Value: 🔒
🔒score
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for tre... more
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intrava... more
Description
Shares
| Market Cap | $12.57B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Douglas E. Godshall |
| IPO Date | 2019-03-07 | CAGR | 1.74% |
| Employees | 1,468 | Website | www.shockwavemedical.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
SWAV chart loading...
Fundamentals
Technicals
| Enterprise Value | $12.45B | P/E Ratio | 78.76 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 17.21 | P/B Ratio | 18.38 |
| P/CF Ratio | 62.67 | P/FCF Ratio | 75.96 |
| EPS | $4.25 | EPS Growth 1Y | -32.49% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 41.42% | Gross Margin | 0.87% |
| Operating Margin | 0.23% | Profit Margin | 0.2% |
| ROE | 0.25% | ROA | 0.09% |
| ROCE | 0.11% | Current Ratio | 11.76 |
| Quick Ratio | 10.73 | Cash Ratio | 3.15 |
| Debt/Equity | 1.15 | Interest Coverage | 26.79 |
| Altman Z Score | 10.32 | Piotroski Score | 6 |